Clinical Trial Update: Semaglutide in Nonalcoholic Fatty Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for semaglutide in nonalcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Zagazig University | Conditions: Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED